CymaBay Therapeutics (CBAY) Rating Reiterated by HC Wainwright

... company's stock valued at $5,712,000 after acquiring an additional 170,126 shares in the last quarter. Finally, Ardsley Advisory Partners raised its position in shares of CymaBay Therapeutics by 66.2% during the 2nd quarter. Ardsley Advisory ...
http://ift.tt/2AgOdqL

Leerink Swann Reiterates "Buy" Rating for CymaBay Therapeutics

... the biopharmaceutical company's stock worth $100,000 after acquiring an additional 140 shares in the last quarter. Ardsley Advisory Partners boosted its stake in CymaBay Therapeutics by 66.2% during the second quarter. Ardsley Advisory Partners now ...
http://ift.tt/2Bnn8zB

CymaBay Therapeutics (CBAY) Rating Reiterated by Leerink Swann

... Wace North America L.P. bought a new position in CymaBay Therapeutics in the 2nd quarter valued at $242,000. Ardsley Advisory Partners grew its stake in CymaBay Therapeutics by 66.2% in the 2nd quarter. Ardsley Advisory Partners now owns 50,210 ...
http://ift.tt/2BldqO6

Brokerages Set CymaBay Therapeutics Inc. (CBAY) Price Target at $14.00

... of the biopharmaceutical company's stock worth $100,000 after acquiring an additional 140 shares during the period. Ardsley Advisory Partners grew its stake in shares of CymaBay Therapeutics by 66.2% during the 2nd quarter. Ardsley Advisory Partners ...
http://ift.tt/2n1GgAR

Abeona Therapeutics Inc. (ABEO) Stock Rating Lowered by Zacks Investment Research

... company's stock worth $580,000 after purchasing an additional 104,038 shares during the last quarter. Ardsley Advisory Partners lifted its stake in Abeona Therapeutics by 33.3% during the second quarter. Ardsley Advisory Partners now owns 60,000 ...
http://ift.tt/2zwDHg3

CymaBay Therapeutics Inc. (CBAY) Receives Average Rating of "Buy" from Brokerages

... Fund Management LLC bought a new position in shares of CymaBay Therapeutics in the 3rd quarter worth $404,000. Ardsley Advisory Partners lifted its holdings in shares of CymaBay Therapeutics by 66.2% in the 2nd quarter. Ardsley Advisory Partners now ...
http://ift.tt/2hIGB67

EAM Investors LLC Invests $4.79 Million in CymaBay Therapeutics Inc. (CBAY) Stock

... at the end of the most recent quarter. Other large investors also recently modified their holdings of the company. Ardsley Advisory Partners lifted its stake in CymaBay Therapeutics by 66.2% during the 2nd quarter. Ardsley Advisory Partners now owns ...
http://ift.tt/2AiU67M

Westchester's DeCicco & Sons Puts Family First

... sion and just don't question it anymore. It's the right thing to do for our employees." DeCicco & Sons stores are in Ardsley, Armonk, Brewster, Harrison, Larchmont, Millwood, and Pelham, and is coming to Somers in 2018.
http://ift.tt/2jacYem

FY2017 EPS Estimates for CymaBay Therapeutics Inc. (CBAY) Cut by Analyst

... biopharmaceutical company's stock valued at $100,000 after acquiring an additional 140 shares in the last quarter. Ardsley Advisory Partners lifted its position in shares of CymaBay Therapeutics by 66.2% in the second quarter. Ardsley Advisory ...
http://ift.tt/2itY4zR

Drugmaker Acorda Plunges After Deaths in Parkinson's Trial

... U.S. regulators said they wouldn't review Acorda's application to sell Inbrija because of questions about the Ardsley, New York-based company's manufacturing. On the call, Cohen said the company plans to resubmit a new drug application for Inbrija ...
http://ift.tt/2zEdiMt

Acorda Shares Plunge After Deaths in Parkinson's Trial

... rter of 2018, after further talks with the Data Safety Monitoring Board and the U.S. health regulator. Shares of the Ardsley, New York-based company plunged 40.4 percent to $16.80 in premarket trading on Wednesday.
http://ift.tt/2iXq3aD

UPDATE 1-Acorda halts enrollment in Parkinson's trial, shares plunge

... rter of 2018, after further talks with the Data Safety Monitoring Board and the U.S. health regulator. Shares of the Ardsley, New York-based company plunged 40.4 percent to $16.80 in premarket trading on Wednesday.
http://ift.tt/2AQkvHh

Drugmaker Acorda Plunges After Deaths in Parkinson's Trial

... U.S. regulators said they wouldn't review Acorda's application to sell Inbrija because of questions about the Ardsley, New York-based company's manufacturing. (Updates share price in the fifth paragraph. An earlier version of this story corrected ...
http://ift.tt/2yJis6e

Kurt Von Emster Sells 50,048 Shares of CymaBay Therapeutics Inc. (CBAY) Stock

... North America L.P. acquired a new position in shares of CymaBay Therapeutics in the 2nd quarter valued at $242,000. Ardsley Advisory Partners boosted its position in shares of CymaBay Therapeutics by 66.2% in the 2nd quarter. Ardsley Advisory ...
http://ift.tt/2hA1l3g

Alabama, Colorado, and New York Students Win Regional Siemens...

... to breast cancer metastasis. Chelsea Wang of Fort Collins, CO, Rachel Li of Poughkeepsie, NY, and Jainil Sutaria of Ardsley, NY, shared the $6,000 team scholarship for developing a novel gel compound that could help bone regeneration in teeth by ...
http://ift.tt/2mnL9Uw

CymaBay Therapeutics Inc. (CBAY) Sees Large Growth in Short Interest

... company's stock worth $5,712,000 after purchasing an additional 170,126 shares during the last quarter. Finally, Ardsley Advisory Partners increased its position in CymaBay Therapeutics by 66.2% in the second quarter. Ardsley Advisory Partners now ...
http://ift.tt/2AzZVd0

Greenburgh Town Supervisor Vows To Work With Edgemont On Becoming A Village

... iatives that will be pursued." The 36.1-square-mile Town of Greenburgh already has six villages within its borders - Ardsley, Dobbs Ferry, Elmsford, Hastings-on-Hudson, and Tarrytown.
http://ift.tt/2AoDIP0

Metro-North Service Will Be Affected By Removal Of Old TZ Bridge Span

... bus to Yonkers Station for continuing train service to Grand Central. Southbound customers traveling to Irvington, Ardsley, Dobbs Ferry, Hastings, Greystone and Glenwood will take the train to Tarrytown and transfer to bus service to Irvington where ...
http://ift.tt/2ApqBNo

Abeona Therapeutics Inc. (ABEO) Trading 0% Higher

... biopharmaceutical company's stock worth $580,000 after purchasing an additional 104,038 shares in the last quarter. Ardsley Advisory Partners raised its position in Abeona Therapeutics by 33.3% in the second quarter. Ardsley Advisory Partners now ...
http://ift.tt/2yKGe5I

16-Year-Old Wants To Become Next Mayor Of Ardsley, Then Go From There

Win or lose during Tuesday's election, 16-year-old David Oks has an eye toward Washington and maybe even the White House. Oks, who is running as an Independent write-in candidate for the office of Mayor in Ardsley, isn't holding his breath about coming out on top.
http://ift.tt/2Aryi6D

Rockland Resident Steps Into The Ring With Ardsley Boxing Club

Palumbo, a Bardonia resident, opened a TITLE Boxing Club in Ardsley at 901 Saw Mill River Road last February and was recently honored by the company with its Rookie of the Year award. Palumbo decided to open up her own gym after trying a boxing workout.
http://ift.tt/2hKFcft